Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair H Kyle

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Cancer Research|December 14, 2011
Targeting quiescent tumor cells via oxygen and IGF-I supplementationAlastair H Kyle, Jennifer H E Baker, Andrew I Minchinton
Radiation Research|June 20, 2002
Carbogen breathing after irradiation enhances the effectiveness of tirapazamine in SiHa tumors but not SCCVII tumors in miceAndrew I Minchinton, Danika A Tonn, Darren P Sutherland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Limited tissue penetration of taxanes: a mechanism for resistance in solid tumorsAlastair H Kyle, Lynsey A Huxham, Devon M Yeoman, et al.
Haematologica|August 18, 2010
Vascularization predicts overall survival and risk of transformation in follicular lymphomaPedro Farinha, Alastair H Kyle, Andrew I Minchinton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2006
Tirapazamine causes vascular dysfunction in HCT-116 tumour xenograftsLynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Cancer Research|September 18, 2004
Microregional effects of gemcitabine in HCT-116 xenograftsLynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Microvascular Research|March 21, 2006
Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assayJennifer H E Baker, Lynsey A Huxham, Alastair H Kyle, et al.
Microvascular Research|November 21, 2007
Exploring vascular dysfunction caused by tirapazamineLynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Molecular Cancer Therapeutics|August 22, 2014
Tissue penetration and activity of camptothecins in solid tumor xenograftsAlastair H Kyle, Jennifer H E Baker, Maria-Jose Gandolfo, et al.
Cancer Research|October 3, 2003
Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependentAlastair H Kyle, Lynsey A Huxham, Jennifer H E Baker, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Cancer Research|December 14, 2011
Targeting quiescent tumor cells via oxygen and IGF-I supplementationAlastair H Kyle, Jennifer H E Baker, Andrew I Minchinton
Radiation Research|June 20, 2002
Carbogen breathing after irradiation enhances the effectiveness of tirapazamine in SiHa tumors but not SCCVII tumors in miceAndrew I Minchinton, Danika A Tonn, Darren P Sutherland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Limited tissue penetration of taxanes: a mechanism for resistance in solid tumorsAlastair H Kyle, Lynsey A Huxham, Devon M Yeoman, et al.
Haematologica|August 18, 2010
Vascularization predicts overall survival and risk of transformation in follicular lymphomaPedro Farinha, Alastair H Kyle, Andrew I Minchinton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2006
Tirapazamine causes vascular dysfunction in HCT-116 tumour xenograftsLynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Cancer Research|September 18, 2004
Microregional effects of gemcitabine in HCT-116 xenograftsLynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Microvascular Research|March 21, 2006
Vascular-specific quantification in an in vivo Matrigel chamber angiogenesis assayJennifer H E Baker, Lynsey A Huxham, Alastair H Kyle, et al.
Microvascular Research|November 21, 2007
Exploring vascular dysfunction caused by tirapazamineLynsey A Huxham, Alastair H Kyle, Jennifer H E Baker, et al.
Molecular Cancer Therapeutics|August 22, 2014
Tissue penetration and activity of camptothecins in solid tumor xenograftsAlastair H Kyle, Jennifer H E Baker, Maria-Jose Gandolfo, et al.
Cancer Research|October 3, 2003
Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependentAlastair H Kyle, Lynsey A Huxham, Jennifer H E Baker, et al.
Pageof 3